A Study to Test the Usefulness And Effectiveness of a Patient Directed Medication Plan for Treating Sudden Recurring Atrial Fibrillation (A-Fib)

Overview

About this study

The purpose of this study is to test the use of patient managed ECG monitoring devices and individually tailored medication plans to allow patients with paroxysmal (sudden) atrial fibrillation return to sinus rhythm without needing to return to the clinic or hospital.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • 18 years and older
  • Has ability to read and write in English
  • Has a diagnosis of paroxysmal atrial fibrillation (PAF)
  • Has an iOS or Android smartphone device that is compatible with the AliveCor monitor
  • Must be able to provide consent
  • Protected populations will neither be specifically included nor excluded from this protocol

Exclusion Criteria

  • Unabe to read and write on a digital mobile device

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

John Beshai

Closed for enrollment

Contact information:

Sandra Gawlowski

(480) 342-1110

Gawlowski.Sandra@mayo.edu

More information

Publications

Publications are currently not available